Assigned Chapter Number 64
Summary
The Stem Cell Freedom Act authorizes licensed physicians to recommend and administer stem cell therapies that are not FDA‑approved, as long as they follow good manufacturing practices and have institutional review board approval or are investigational products. Health insurers may choose to cover the cost of these therapies, and the state medical board cannot discipline doctors for providing them if they meet medical standards of care. State officials may not block patient access, and no private lawsuits can be filed against providers who comply with the act.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SF 48 changes status, plus AI-powered summaries and stage predictions.
Sign up free